Métabolisme des médicaments

vignette|La formation de deux métabolites de la zopiclone, la N-desméthylzopiclone et la zopiclone-N-oxyde. Créé avec ChemDoodle 8.0.0.3b et Adobe Le métabolisme des médicaments est la transformation, par des enzymes, d'un médicament en un ou plusieurs autres composés actifs ou inactifs médicalement. De nombreux organes le réalisent, reins, poumons, intestin, mais le principal est le foie. La branche qui étudie le métabolisme des médicaments est la pharmacocinétique. Références Catégorie:Pharmacologie

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (100)

Publications associées

Chargement

Personnes associées (44)

Personnes associées

Chargement

Unités associées (18)

Unités associées

Chargement

Concepts associés (40)

Concepts associés

Chargement

Cours associés (20)

Cours associés

Chargement

Séances de cours associées (45)

Séances de cours associées

Chargement

Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches

Vassily Hatzimanikatis, Ljubisa Miskovic, Aikaterini Zisaki

Drug discovery and development is a high-risk enterprise that requires significant investments in capital, time and scientific expertise. The studies of xenobiotic metabolism remain as one of the main topics in the research and development of drugs, cosmetics and nutritional supplements. Antihypertensive drugs are used for the treatment of high blood pressure, which is one the most frequent symptoms of the patients that undergo cardiovascular diseases such as myocardial infraction and strokes. In current cardiovascular disease pharmacology, four drug clusters - Angiotensin Converting Enzyme Inhibitors, Beta-Blockers, Calcium Channel Blockers and Diuretics - cover the major therapeutic characteristics of the most antihypertensive drugs. The pharmacokinetic and specifically the metabolic profile of the antihypertensive agents are intensively studied because of the broad inter-individual variability on plasma concentrations and the diversity on the efficacy response especially due to the P450 dependent metabolic status they present. Several computational methods have been developed with the aim to: (i) model and better understand the human drug metabolism; and (ii) enhance the experimental investigation of the metabolism of small xenobiotic molecules. The main predictive tools these methods employ are rule-based approaches, quantitative structure metabolism/activity relationships and docking approaches. This review paper provides detailed metabolic profiles of the major clusters of antihypertensive agents, including their metabolites and their metabolizing enzymes, and it also provides specific information concerning the computational approaches that have been used to predict the metabolic profile of several antihypertensive drugs.

Bentham Science Publishers2015

Chargement

NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism

Anush Chiappino-Pepe, Noushin Hadadi, Jasmin Maria Hafner, Vassily Hatzimanikatis, Homa Mohammadi Peyhani

The discovery of a drug requires over a decade of intensive research and financial investments – and still has a high risk of failure. To reduce this burden, we developed the NICEdrug.ch resource, which incorporates 250,000 bioactive molecules, and studied their enzymatic metabolic targets, fate, and toxicity. NICEdrug.ch includes a unique fingerprint that identifies reactive similarities between drug–drug and drug–metabolite pairs. We validated the application, scope, and performance of NICEdrug.ch over similar methods in the field on golden standard datasets describing drugs and metabolites sharing reactivity, drug toxicities, and drug targets. We use NICEdrug.ch to evaluate inhibition and toxicity by the anticancer drug 5-fluorouracil, and suggest avenues to alleviate its side effects. We propose shikimate 3-phosphate for targeting liver-stage malaria with minimal impact on the human host cell. Finally, NICEdrug.ch suggests over 1300 candidate drugs and food molecules to target COVID-19 and explains their inhibitory mechanism for further experimental screening. The NICEdrug.ch database is accessible online to systematically identify the reactivity of small molecules and druggable enzymes with practical applications in lead discovery and drug repurposing.

2021

Chargement

Mechanistic insights into bacterial metabolic reprogramming from omics-integrated genome-scale models

Anush Chiappino-Pepe, Noushin Hadadi, Florence Mehl, Merten Morales, Vikash Kumar Pandey

Understanding the adaptive responses of individual bacterial strains is crucial for microbiome engineering approaches that introduce new functionalities into complex microbiomes, such as xenobiotic compound metabolism for soil bioremediation. Adaptation requires metabolic reprogramming of the cell, which can be captured by multi-omics, but this data remains formidably challenging to interpret and predict. Here we present a new approach that combines genome-scale metabolic modeling with transcriptomics and exometabolomics, both of which are common tools for studying dynamic population behavior. As a realistic demonstration, we developed a genome-scale model of Pseudomonas veronii 1YdBTEX2, a candidate bioaugmentation agent for accelerated metabolism of mono-aromatic compounds in soil microbiomes, while simultaneously collecting experimental data of P. veronii metabolism during growth phase transitions. Predictions of the P. veronii growth rates and specific metabolic processes from the integrated model closely matched experimental observations. We conclude that integrative and network-based analysis can help build predictive models that accurately capture bacterial adaptation responses. Further development and testing of such models may considerably improve the successful establishment of bacterial inoculants in more complex systems.

NATURE PUBLISHING GROUP2020

Chargement

Cytochrome P450

Les cytochromes P450 (CYP450) sont des hémoprotéines — protéines ayant une molécule d'hème comme cofacteur — qui interviennent dans les réactions d'oxydoréduction d'un grand nombre de grosses ou de p

Pharmacologie

La pharmacologie est une discipline scientifique du vivant, subdivision de la biologie, qui étudie les mécanismes d'interaction entre une substance active et l'organisme dans lequel elle évolue, de f

Paracétamol

Le paracétamol, aussi appelé acétaminophène, est un composé chimique utilisé comme antalgique (anti-douleur) et antipyrétique (anti-fièvre), qui figure parmi les médicaments les plus communs, utilis

BIO-478: Pharmacology and pharmacokinetics

This course introduces the student to the fudamentals of pharmacology, pharmacokinetics and drug-receptor interactions. It discusses also pharmacogenetics and chronopharmacology, to exemplify the challenges of personalized medicine.

CH-210: Biochemistry

Les constituants biochimiques de l'organisme, protéines, glucides, lipides, à la lumière de l'évolution des concepts et des progrès en biologie moléculaire et génétique, sont étudiés.

ENV-103: Biology

Diversité du monde vivant, rôle et action des Procaryotes dans la biosphère. Fonctionnement biochimique des êtres vivants comprenant les voies métaboliques centrales et les fonctions des biomolécules majeures. Rôle central joué par l'information génétique, des mécanismes évolutifs et de régulation.